Aging and comprehensive molecular profiling in acute myeloid leukemia.

Proc Natl Acad Sci U S A · 2024 · PMC10927507 · PMID 38422020

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

borderline significanceP = 0.056so close (0.05 < p ≤ 0.1)

In addition, HSCT could significantly improve the outcome of CH-MDS-AML patients ( P < 0.001), while it showed borderline significance in the CH-AML ( P = 0.056) and other GF- group ( P = 0.067).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.